{"url_path":"/sec/wve/8-k/2026-05-18/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1631574/0001193125-26-229076-index.html","accession_number":"0001193125-26-229076","cik":"0001631574","ticker":"WVE","issuer_name":"Wave Life Sciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1631574/0001193125-26-229076-index.html","primary_entity_key":"0001631574","primary_entity_name":"Wave Life Sciences Ltd."},"word_count":102,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\nThe following exhibit relating to Item 7.01 is furnished and not filed:\n\n \n\nExhibit No.\n  \nDescription\n\n99.1\n  \n[Press Release issued by Wave Life Sciences Ltd. dated May 18, 2026](d154261dex991.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nWAVE LIFE SCIENCES LTD.\n\nBy:\n \n\n/s/ Paul B. Bolno, M.D.\n\n \nPaul B. Bolno, M.D.\n\n \nPresident and Chief Executive Officer\n\nDate: May 18, 2026"}